StreetInsider.com News Articles

Form 4 PMV Pharmaceuticals, For: Jun 04 Filed by: Stelzer Laurie

Fri, 05 Jun 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260605/26611633.html

Form 4 PMV Pharmaceuticals, For: Jun 04 Filed by: Stelzer Laurie

Fri, 05 Jun 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260605/26611633.html

Form 4 PMV Pharmaceuticals, For: Jun 04 Filed by: LEVINE ARNOLD J

Fri, 05 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260605/26611540.html

Form 4 PMV Pharmaceuticals, For: Jun 04 Filed by: LEVINE ARNOLD J

Fri, 05 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260605/26611540.html

Form 4 PMV Pharmaceuticals, For: Jun 04 Filed by: Gallagher Carol Giltner

Fri, 05 Jun 2026 16:25:00 -0400

si-local-file:///var/storage/secattach/20260605/26611433.html

Form 4 PMV Pharmaceuticals, For: Jun 04 Filed by: Gallagher Carol Giltner

Fri, 05 Jun 2026 16:25:00 -0400

si-local-file:///var/storage/secattach/20260605/26611433.html

Form 4 PMV Pharmaceuticals, For: Jun 04 Filed by: FLOWERS KIRSTEN

Fri, 05 Jun 2026 16:23:00 -0400

si-local-file:///var/storage/secattach/20260605/26611404.html

Form 4 PMV Pharmaceuticals, For: Jun 04 Filed by: FLOWERS KIRSTEN

Fri, 05 Jun 2026 16:23:00 -0400

si-local-file:///var/storage/secattach/20260605/26611404.html

Form 4 PMV Pharmaceuticals, For: Jun 04 Filed by: BAUM CHARLES M

Fri, 05 Jun 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260605/26611375.html

Form 4 PMV Pharmaceuticals, For: Jun 04 Filed by: BAUM CHARLES M

Fri, 05 Jun 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260605/26611375.html

Form 8-K PMV Pharmaceuticals, For: Jun 04

Fri, 05 Jun 2026 08:10:00 -0400

si-local-file:///var/storage/secattach/20260605/26608560.html

Form 8-K PMV Pharmaceuticals, For: Jun 04

Fri, 05 Jun 2026 08:10:00 -0400

si-local-file:///var/storage/secattach/20260605/26608560.html

Form SCHEDULE 13G/A PMV Pharmaceuticals, Filed by: Euclidean Capital LLC

Fri, 15 May 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260515/26505018.html

Form SCHEDULE 13G/A PMV Pharmaceuticals, Filed by: Euclidean Capital LLC

Fri, 15 May 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260515/26505018.html

PMV Pharmaceuticals Inc. (PMVP) PT Lowered to $5 at Oppenheimer

Wed, 13 May 2026 08:40:41 -0400

Oppenheimer analyst Jeff Jones lowered the price target on PMV Pharmaceuticals Inc. (NASDAQ: PMVP) to $5.00 (from $6.00) while maintaining a Outperform rating.

PMV Pharmaceuticals, Inc. (PMVP) Tops Q1 EPS by 1c

Tue, 12 May 2026 08:46:44 -0400

PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) reported Q1 EPS of ($0.34), $0.01 better than the analyst estimate of ($0.35).

For earnings history and earnings-related data on PMV Pharmaceuticals, Inc. (PMVP) click here.

Form 10-Q PMV Pharmaceuticals, For: Mar 31

Tue, 12 May 2026 08:01:00 -0400

si-local-file:///var/storage/secattach/20260512/26473388.html

Form 10-Q PMV Pharmaceuticals, For: Mar 31

Tue, 12 May 2026 08:01:00 -0400

si-local-file:///var/storage/secattach/20260512/26473388.html

PMV Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Highlights

Tue, 12 May 2026 08:00:00 -0400

Rezatapopt granted Orphan Drug Designation by the U.S. Food and Drug Administration for the treatment of TP53 Y220C positive ovarian cancer
New England Journal of Medicine published first-in-human rezatapopt data showing selective reactivation of mutant p53 in advanced solid tumors
Rezatapopt New Drug Application submission for platinum-resistant/refractory ovarian cancer planned in first quarter of 2027
Cash, cash equivalents, and marketable securities of $93.5 million as of March 31, 2026 providing expected cash runway to end of second quarter of 2027